Here’s The Volatile Biotech Stock One Analyst Thinks Could Boom 175%

Shares of Synergy Pharmaceuticals (SGYP) rose 10% to $4.00 in Friday trading. On Thursday, Cantor Fitzgerald started coverage of the New York firm’s shares with an overweight rating and an $11 price target.